The concept of trial launched in Ukraine in 2017 with POEM design and 36-months duration is presented. It aims to investigate the impact of two target levels of urate-lowering therapy caused by hyperuricemia on kidney fu...
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that have certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifesta...
Background. In recent years, the clinical course of pyelonephritis in children is characterized by an increase in the number of latent and subclinical forms of the disease, increased resistance to traditional antibiotic...
The impact of urate-lowering therapy on kidney function (IMPULsKF)
The concept of trial launched in Ukraine in 2017 with POEM design and 36-months duration is presented. It aims to investigate the impact of two target levels of urate-lowering therapy caused by hyperuricemia on kidney fu...
Features of renal involvement in systemic connective tissue diseases
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that have certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifesta...
Loop Diuterics: What Effect Do WE Expect from Different Doses and Various Forms of Release?
.
National Guideline Clearinghouse Guideline summary NGC: 2016. Patient blood management guidelines Module 6. Neonatal and paediatrics
.
Markers of fibrillogenic disorders in children with different variants of pyelonephritis
Background. In recent years, the clinical course of pyelonephritis in children is characterized by an increase in the number of latent and subclinical forms of the disease, increased resistance to traditional antibiotic...